NCT00862836 Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD) Status TERMINATED Phase PHASE1/PHASE2
NCT00856791 Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients Status COMPLETED Phase PHASE2
NCT00856453 Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer Status TERMINATED Phase NA
NCT00856180 Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies Status COMPLETED Phase PHASE2
NCT00855998 Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer Status UNKNOWN Phase N/A
NCT00854282 The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression Status UNKNOWN Phase NA
NCT00849667 Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse Status TERMINATED Phase PHASE3
NCT00846612 Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00844506 p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00842582 Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer Status WITHDRAWN Phase PHASE1
NCT00842452 Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE1
NCT00840450 Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin Status TERMINATED Phase PHASE2
NCT00838656 Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Status UNKNOWN Phase PHASE2
NCT00837993 Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System Status COMPLETED Phase N/A
NCT00831636 A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00829959 Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) Status COMPLETED Phase N/A
NCT00826150 Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00825201 Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity Status COMPLETED Phase PHASE1